asparagine has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bressan, D; Cannell, IG; Hannon, GJ; Kania, K; Nicholls, A; Sawicka, K; Wild, SA | 1 |
1 other study(ies) available for asparagine and ER-Negative PR-Negative HER2-Negative Breast Cancer
| Article | Year |
|---|---|
Clonal transcriptomics identifies mechanisms of chemoresistance and empowers rational design of combination therapies.
Topics: Animals; Asparagine; Drug Resistance, Neoplasm; Humans; Mice; Nuclear Proteins; Taxoids; Transcription Factors; Transcriptome; Triple Negative Breast Neoplasms | 2022 |